Injectafer denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Injectafer as Non-Formulary

UnitedHealthcare's drug formulary — its approved list of covered medications — does not always include Injectafer (ferric carboxymaltose) at a preferred tier, or may exclude it outright in favor of other IV iron products. A non-formulary denial means the plan's pharmacy or medical benefit structure does not automatically cover this specific agent. However, "not on the preferred list" is not the same as "medically inappropriate," and a non-formulary denial is one of the most straightforwardly appealable denial types.

## Why This Denial Is Appealable

Insurers are required to offer a formulary exception process. If your clinician can document that a formulary alternative is contraindicated, clinically unsuitable, or has already been tried and failed for your specific condition, the plan must consider covering the non-formulary drug. A blanket non-formulary denial without evaluating your individual clinical circumstances does not satisfy the standard for a valid denial.

## Your Federal Appeal Rights

• Formulary exception request: This is your first step — often faster than a full internal appeal. Ask your prescriber to submit a formulary exception with supporting clinical documentation.
• Internal appeal (ACA §2719): If the exception is denied, file a formal written internal appeal. UHC must review it under its clinical criteria.
• External review: After exhausting internal appeals, you may request independent external review. The external reviewer applies accepted clinical standards, not UHC's formulary preferences.
• ERISA §503: Employer-sponsored self-funded plans are subject to ERISA's full-and-fair review; request the complete administrative record.
• Expedited review: Available for urgent clinical situations.
• Timeline: File external review within four months of your final internal denial letter.

## Documentation to Gather

1. Formulary alternative history: Names, dates, and documented outcomes for any formulary IV iron products that were tried or considered. 2. Clinical rationale for Injectafer specifically: Your prescriber's explanation of why Injectafer — rather than a formulary alternative — is medically necessary for your case. 3. Diagnosis and severity documentation: Lab values, clinical notes, and specialist records establishing the nature and severity of your iron deficiency. 4. Prescriber medical-necessity letter: Addressed specifically to the formulary exception or appeal, citing the applicable clinical guideline organization's position on agent selection. 5. UHC's exception and appeals policy: Obtain UHC's published formulary exception criteria so your submission addresses each requirement directly.

## Criteria-Mapping Structure

For non-formulary appeals, the mapping table should address two parallel sets of criteria: (1) UHC's formulary exception requirements and (2) the clinical reasons why alternatives are unsuitable. Left column: each exception criterion verbatim from UHC's published policy. Right column: the specific chart fact, date, and clinician note that satisfies or addresses each criterion. Attach this table to both the exception request and any subsequent internal appeal. A well-structured submission significantly reduces the likelihood of a second denial on the same grounds.